A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
Recruiting · NCT07325136 · Registry updated 2026-09-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Phase 1 / Phase 2 | 2026-09-14 | NCT07325136 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centrul de Oncologie Sf. Nectarie SRL | Craiova | Romania | 2 |
| Duke Cancer Institute | Durham | United States | 47 |
| Hospital Universitario 12 de Octubre | Madrid | Spain | 359 |
| Istituto Clinico Humanitas | Rozzano | Italy | 17 |
| Karmanos Cancer Institute | Detroit | United States | 153 |
| Oncohelp Medical Center | Timișoara | Romania | 3 |
| Roswell Park Cancer Institute | Buffalo | United States | 382 |
| Scri Oncology Partners | Nashville | United States | 156 |
| Shanghai East Hospital | Shanghai | China | 38 |
| University Hospitals Cleveland Medical Center | Cleveland | United States | 234 |